Browse by Medical Category
Lab phone: 617-724-9584
Neurology Access Center: 1-855-644-6387
Scott R. Plotkin, MD, PhD - Basic science and clinical research for NF1, NF2, and schwannomatosis.
Research Investigator Profile
Scott R. Plotkin, MD, PhD
Professor of Neurology,Harvard Medical School Assistant Neurologist,Massachusetts General Hospital Director, Neurofibromatosis Clinic Director, MGH-DFCI-BWH Neuro-Oncology Fellowship Program
Our clinical research group is interested in characterizing the phenotype of patients with tumor suppressor syndromes such as neurofibromatosis (NF). We are performing whole-body MRI scans in patients to measure the distribution and volume of internal nerve sheath tumors in patients with NF1, NF2, and schwannomatosis. We are also using laser scanning techniques to measure the number and height of cutaneous tumors in subjects with NF1. The second clinical research interest is in developing new therapies for patients with NF. Thus, we are designing and executing clinical trials for these diseases using small molecule inhibitors of growth factor pathways. The final interest in our group is to understand the genetic basis for schwannomatosis, the third for of NF. We are studying blood and tumor specimens from these patients to determine the role of the NF2 and INI1 genes in tumor suppression.
Research Lab: Stephen E. and Catherine Pappas Center for Neuro-Oncology
Neurofibromatosis, schwannomatosis, primary brain tumors, metastatic brain tumor
Clinical website address
Back to Top